Advertisement
News
Subscribe to MDT Magazine News

Inovio Pharmaceuticals' Dual-Antigen SynConâ„¢ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial

February 2, 2011 1:35 am | by Bio-Medicine.Org | Comments

BLUE BELL, Pa., Feb. 2, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper in the journal Human Vaccines detailing potent...

TOPICS:

Dawn Phillips Named as Vice President, Business Development for Catastrophic & Home Health Services

February 2, 2011 1:35 am | by Bio-Medicine.Org | Comments

JACKSONVILLE, Fla., Feb. 2, 2011 /- MSC, a leader in care management solutions serving post-injury workers' compensation patients announced today that Dawn Phillips has been named Vice President of Business Development for its Catastrophic & Home Health Services division....

TOPICS:

Too big to stop? Obama's overhaul lumbers on

February 1, 2011 10:45 pm | by RICARDO ALONSO-ZALDIVAR - Associated Press - Associated Press | Comments

It has too much momentum for one judge to stop it.Most insurers, hospital executives and state officials expect they'll keep carrying out President Barack Obama's health care overhaul even after a federal judge cast its fate in doubt by declaring all of it unconstitutional."It's still the law...

Advertisement

Recurrent Energy Secures 180 Mw Solar Module Supply For Feed-In Tariff Projects In Ontario, Canada.

February 1, 2011 8:35 pm | by I-Micronews | Comments

Energy today announced that it has entered into an agreement with Celestica, a global leader in the delivery of end-to-end product lifecycle solutions, for the supply of solar modules for projects awarded within the renewable energy Feed-in Tariff (FIT) program of the Ontario Power Authority (OPA).

Molex unveils EXTreme Ten60Power high-current connectors

February 1, 2011 8:34 pm | by I-Micronews | Comments

Molex Inc. has introduced a new version of its EXTreme Ten60Power? High-Current Connectors.

<i>Policy Tracker: </i>Studies: Many providers to adopt EHR for incentives; Businesses won't find health care certainty in D.C.

February 1, 2011 8:34 pm | by Mass High Tech: The Journal of New England Technology | Comments

Four-fifths of the nation's hospitals, and 41 percent of office-based physicians intend to take advantage of federal incentive payments for adoption and meaningful use of certified electronic health records technology; In separate news, the U.S. House approved legislation repealing last...

CardioComm Solutions, Inc. Close Private Placement Equity Financing and Addition to Board of Directors

February 1, 2011 3:45 pm | by The Associated Press | Comments

CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company") today announced that it has closed its previously announced non-brokered private placement equity financing. Under the financing, the Company issued 3,000,000 units at a price of $0.05 per unit for gross...

Izard Nobel LLP Announces Class Action Lawsuit Against MannKind Corporation

February 1, 2011 1:45 pm | by The Associated Press | Comments

The law firm of Izard Nobel LLP, which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Central District of California on behalf of...

Advertisement

Cyberonics says FDA approved AspireHC generator

February 1, 2011 1:45 pm | by The Associated Press | Comments

Cyberonics Inc. said Tuesday that U.S. regulators approved a new generator used in nerve stimulation therapy.The company said the Food and Drug Administration approved its AspireHC generator. AspireHC will be available in limited release during the company's fiscal first quarter, which ends...

Blue Shield submits to rate hike delay in Calif.

February 1, 2011 12:45 pm | by SHAYA TAYEFE MOHAJER - Associated Press - Associated Press | Comments

Blue Shield of California has joined other health insurers in delaying implementation of new rate hikes for individual policyholders, after initially declining to do so despite a request from the state's new insurance commissioner.In a statement Tuesday, the San Francisco-based insurer...

Seattle Genetics plans public stock offering

February 1, 2011 12:45 pm | by The Associated Press | Comments

Biotechnology company Seattle Genetics Inc. said Tuesday it plans to sell shares of common stock to the public.The company did not disclose the size or price of its offering, and said the sale may not go through. It said Jefferies & Co. and JPMorgan Securities are the joint book-running...

Tax benefit boosts Vascular Solutions 4Q profit

February 1, 2011 12:45 pm | by The Associated Press | Comments

Vascular Solutions Inc. said Tuesday its profit jumped almost tenfold in the fourth quarter because of a large income tax benefit.The company, which makes devices used by surgeons to seal punctures in arteries, said its net income grew to $15 million, or 87 cents per share, from $1.6 million,...

Brain can learn to overcome sleep apnea: U of T scientist

February 1, 2011 12:36 pm | by EurekAlert | Comments

(University of Toronto) New research from the University of Toronto could provide some restful nights for the 18 million North Americans who suffer from obstructive sleep apnea.

TOPICS:

New clinical trial to determine ovarian cancer risks in African-American women

February 1, 2011 12:35 pm | by EurekAlert | Comments

(University Hospitals Case Medical Center) University Hospitals Case Medical Center and Case Western Reserve University School of Medicine are conducting a new study addressing lack of knowledge about causes and risk factors for ovarian cancer in African-American women. Ovarian cancer is...

TOPICS:

Reportlinker Adds Bevacizumab - Comprehensive Patent Search

February 1, 2011 12:35 pm | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 1, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Bevacizumab - Comprehensive patent search http://www.reportlinker.com/p0366187/Bevacizumab---Comprehensive-patent-search.html Eliminate unnecessary risk with the industry...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading